We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

395 hedge funds and large institutions have $13.6B invested in Intra-Cellular Therapies Inc. in 2025 Q1 according to their latest regulatory filings, with 159 funds opening new positions, 88 increasing their positions, 118 reducing their positions, and 149 closing their positions.

New
Increased
Maintained
Reduced
Closed

247% more funds holding in top 10

Funds holding in top 10: 15 → 52 (+37)

68% more capital invested

Capital invested by funds: $8.08B → $13.6B (+$5.52B)

29% more call options, than puts

Call options by funds: $367M | Put options by funds: $284M

2% more funds holding

Funds holding: 387 → 395 (+8)

7% more first-time investments, than exits

New positions opened: 159 | Existing positions closed: 149

25% less repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 118

Holders
395
Holders Change
+8
Holders Change %
+2.07%
% of All Funds
5.3%
Holding in Top 10
52
Holding in Top 10 Change
+37
Holding in Top 10 Change %
+246.67%
% of All Funds
0.7%
New
159
Increased
88
Reduced
118
Closed
149
Calls
$367M
Puts
$284M
Net Calls
+$82.6M
Net Calls Change
+$68.2M

Top Buyers

Rank Fund Capital Flow
1
PCM
Pentwater Capital Management
Florida
+$647M
2
HI
HBK Investments
Texas
+$546M
3
DKCM
Davidson Kempner Capital Management
New York
+$434M
4
UOC
UBS O'Connor
Illinois
+$383M
5
FCM
Farallon Capital Management
California
+$381M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.05B
2
JP Morgan Chase
JP Morgan Chase
New York
-$544M
3
Invesco
Invesco
Georgia
-$373M
4
ACA
Avoro Capital Advisors
New York
-$302M
5
WA
Wasatch Advisors
Utah
-$271M
Name Holding Trade Value Shares
Change 		Change in
Stake
VAM
176
Vazirani Asset Management
New York
$3.3M +$3.12M +25,000 New
GCM
177
Greenland Capital Management
New York
$3.2M +$3.02M +24,224 New
EGM
178
Engineers Gate Manager
New York
$3.17M +$75.1K +603 +3%
SEI Investments
179
SEI Investments
Pennsylvania
$3.12M -$21.7M -174,169 -88%
EAM
180
Erste Asset Management
Austria
$3.08M – – –
Canada Life
181
Canada Life
Manitoba, Canada
$3.06M +$91.2K +732 +3%
CC
182
Carlson Capital
Texas
$3.03M +$2.87M +23,000 New
CM
183
Capula Management
Cayman Islands
$3.01M +$2.84M +22,800 New
PC
184
Paulson & Co
New York
$2.84M +$2.68M +21,500 New
CUAMC
185
China Universal Asset Management Company
China
$2.81M -$144K -1,152 -5%
GC
186
Guggenheim Capital
Illinois
$2.8M -$1.11M -8,878 -29%
Cerity Partners
187
Cerity Partners
New York
$2.7M -$2.62M -20,997 -51%
BCA
188
Burren Capital Advisors
Gibraltar
$2.65M +$2.5M +20,074 New
DTL
189
Dynamic Technology Lab
Singapore
$2.58M +$2.44M +19,560 New
Creative Planning
190
Creative Planning
Kansas
$2.55M +$177K +1,420 +8%
ECM
191
ExodusPoint Capital Management
New York
$2.49M +$574K +4,604 +32%
GAM
192
Gotham Asset Management
New York
$2.44M +$935K +7,501 +68%
Stifel Financial
193
Stifel Financial
Missouri
$2.43M -$1.96M -15,763 -46%
LIP
194
Lighthouse Investment Partners
Florida
$2.33M +$2.2M +17,666 New
Carson Wealth (CWM LLC)
195
Carson Wealth (CWM LLC)
Nebraska
$2.22M +$328K +2,635 +19%
AAI
196
Aequim Alternative Investments
California
$1.98M +$1.87M +15,000 New
BPAMU
197
BTG Pactual Asset Management US
New York
$1.98M +$1.87M +15,000 New
Nomura Holdings
198
Nomura Holdings
Japan
$1.89M +$1.78M +14,313 New
X
199
Xponance
Pennsylvania
$1.86M +$60.3K +484 +4%
QT
200
Quantbot Technologies
New York
$1.72M +$1.62M +13,020 New
6 7
8
9 10

ITCI Hedge Fund Activity: Q1 2025 in Review

395 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q1 2025, worth a combined $13.6B — up 68% from $8.08B a quarter earlier.

Buyers outnumbered sellers: 159 funds opened new ITCI positions and 149 closed out — a net gain of 10 holders — while 88 added to existing stakes and 118 trimmed.

The largest buyer was Pentwater Capital Management, opening a new position worth an estimated $647M. The largest seller was Fidelity Investments, cutting an estimated $1.05B.

  • 395 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q1 2025, up from 387 in Q4 2024.
  • Funds reported $13.6B of Intra-Cellular Therapies Inc. stock for Q1 2025, up 68% quarter-over-quarter.
  • 159 funds opened new Intra-Cellular Therapies Inc. positions in Q1 2025 and 149 closed out, a net change of +10 holders.
  • The largest Intra-Cellular Therapies Inc. buyer in Q1 2025 was Pentwater Capital Management, an estimated $647M added.
  • The largest Intra-Cellular Therapies Inc. seller in Q1 2025 was Fidelity Investments, an estimated $1.05B sold.

Based on aggregated 13F filings for Q1 2025.